NCT02293018View on ClinicalTrials.gov

Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Acne Vulgaris
Interventions
DRUG

0.75% (w/w) MTC896 Gel Once Daily

DRUG

0.75% (w/w) MTC896 Gel Twice Daily

DRUG

1.5% (w/w) MTC896 Gel Once Daily

Trial Locations (3)

77845

J&S Studies, College Station

78759

DermResearch, Austin

99204

Premier Clinical Research, Spokane

All Listed Sponsors
lead

Mimetica Pty Limited

INDUSTRY

NCT02293018 - Pharmacokinetic Study of MTC896 Gel in Subjects With Acne | Biotech Hunter | Biotech Hunter